5 results
8-K
EX-99.1
ACET
Adicet Bio Inc
10 May 24
Regulation FD Disclosure
6:09am
Annual Meeting 2024Baltimore, MD Shon Green, PhD VP, Nonclinical Development
ADI-270: Designed to address multiple refractory cancers CAR utilizes
8-K
EX-99.1
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
Session I
Presenting Author: Shon Green, Ph.D.
Date & Time: May 10, 2024 at 5:00 PM EST
About Adicet Bio, Inc.
Adicet Bio, Inc. is a clinical stage
8-K
EX-10.23
ACET
Adicet Bio Inc
16 Sep 20
Entry into a Material Definitive Agreement
9:59am
. Green Building council or Energy Star rating and/or compliance system or program (collectively, “Conservation Costs”);
(vii) The cost of all insurance
S-4
EX-10.37
ACET
Adicet Bio Inc
23 Jun 20
Registration of securities issued in business combination transactions
12:28pm
and Environmental Design) rating or compliance system or program, including that currently coordinated through the U.S. Green Building council or Energy
8-K
EX-99.2
ACET
Adicet Bio Inc
7 Feb 19
Regulation FD Disclosure
8:01am
250nM Everolimus Green = Neurofilaments Red = Neuron cell bodies (DARPP-32) 50nM RTB101 300nM RTB101 10nM RTB101 + 250 nM Everolimus 30nM RTB101 + 250 nM
- Prev
- 1
- Next